AI in Action E136: Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering

,  | October 20 2020 | JP Valentine

Welcome to episode 136 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering. Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering’s technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, they provide unparalleled computational biology services to leading pharmaceutical and biotechnology companies.

In the show, Jenny and Jason will chat about: 

Transitioning from academia into industry 

How Immuneering are applying AI to improve drug discovery 

What makes them stand out from the competition 

Interesting projects they are working on 

Why they love working at Immuneering 

What they look for in the hiring process 

What’s in store for the future 

To find out more about Jenny & Jason and the great work at they do at Immuneering, check out the website www.immuneering.com or follow them on Twitter @immuneering. You can also connect with Jenny and Jason on Linkedin.

What did you make of Jenny and Jason’s podcast? Where do you see the future of AI within drug discovery and the healthcare sector heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

Welcome to episode 136 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering. Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering’s technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, they provide unparalleled computational biology services to leading pharmaceutical and biotechnology companies.

In the show, Jenny and Jason will chat about: 

Transitioning from academia into industry 

How Immuneering are applying AI to improve drug discovery 

What makes them stand out from the competition 

Interesting projects they are working on 

Why they love working at Immuneering 

What they look for in the hiring process 

What’s in store for the future 

To find out more about Jenny & Jason and the great work at they do at Immuneering, check out the website www.immuneering.com or follow them on Twitter @immuneering. You can also connect with Jenny and Jason on Linkedin.

What did you make of Jenny and Jason’s podcast? Where do you see the future of AI within drug discovery and the healthcare sector heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

related podcasts

ServiceNow Series E154: Shannon Chapman, Director of IT Service Delivery at Norwegian Cruise Line Holdings Ltd.

 Welcome to episode 154 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E506: Nilanjan Chakravorty, Chief Data Officer at EmpiRx Health

 Welcome to episode 506 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

ServiceNow Series E153: Amy Giovannucci, Platforms Capability Lead & Managing Director at Accenture Federal Services

 Welcome to episode 153 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More